A Healthy Disruption

Social Determinants of Health in the Virtual Care Setting

A Healthy Disruption

Date: November 17, 2020
Time: 11:00 am – 12:00 pm PST

Panelists:

Kate Wollin, ScD, FACSM, FSBM (Moderator)

Entrepreneurial Executive and Behavioral Epidemiologist

Gina Merchant, Ph.D.

Behavioral Scientist

Aditi U. Joshi MD, MSc, FACEP

Medical Director of JeffConnect

Gary Bennett, Ph.D.

Bishop-MacDermott Family Professor of Psychology & Neuroscience, Global Health and Medicine and Vice Provost for Undergraduate Education at Duke University

In the time of COVID-19, digital health and telehealth capacities are ramping up. These technologies often point to solutions for specific chronic conditions. In this webinar, learn from experts about:

  • How chronic conditions are often underpinned by behavioral complexities such as smoking, diet, alcohol use, physical activity, etc., and
  • How digital and healthtech companies can integrate behavioral, social, and clinical care data into product design to create context-aware, intelligent solutions
Kate Wolin, ScD, FACSM, FSBM

Kate Wolin, ScD, FACSM, FSBM

Entrepreneurial Executive and Behavioral Epidemiologist

Dr. Kate Wolin is an entrepreneurial executive and behavioral epidemiologist. After earning her doctorate at Harvard, she built a successful academic medicine career leading research at the intersection of behavior change and chronic disease outcomes. Seeking to bridge evidence-based programs and commercial scale, Kate transitioned to industry serving as CEO and co-founder of ScaleDown, a clinically-proven weight loss program that leveraged the science of self-regulation and daily self weighing. ScaleDown was acquired by Anthem, Inc in December 2017. Dr. Wolin subsequently served as Chief Science Officer of a large PE-backed employer health company. She is a co-founder of Coeus Health, which translates research-tested behavior change programs into scalable SAAS solutions. Dr. Wolin consults with companies to use health behavior change and personalization science to efficiently build and scale engaging and effective digital health solutions. Dr. Wolin is an entrepreneur-in-residence at the Booth School of Business at the University of Chicago and leads the healthcare track for the Zell Fellows entrepreneurship program at the Kellogg School of Management at Northwestern University.

Gina Merchant, PhD

Gina Merchant, PhD

Behavioral Scientist

Dr. Merchant is a Behavioral Scientist specializing in digital health product design, development, research, and strategy. She has experience in startup environments and market-leading medical device companies, and she is adept at bringing the scientific method to the business arena. Dr. Merchant is an expert on deriving actionable insights from real-world data across behavioral domains including physical activity, sleep, and therapy adherence. Her work spans small data, tightly controlled experiments to unstructured big data, and large clinical trials. Dr. Merchant leverages novel study designs to address population health problems as well as to personalize the experience to the individual. Dr. Merchant challenges the industry to deliver transparent and truthful marketing claims about its health tech products. She is also an advocate for increasing the presence, participation, and equitable representation of women and BIPOC in STEM and industry-facing roles. Dr. Merchant is an author of more than 20 peer-reviewed publications; works at the intersection of public health, psychology, and technology. Ph.D. in Public Health from UC San Diego/San Diego State University, MA in Experimental Psychology from Cal State San Marcos, and BA in Psychology from UC San Diego.

Aditi U Joshi MD, MSc, FACEP

Aditi U Joshi MD, MSc, FACEP

Medical Director of JeffConnect

Aditi U Joshi is the Medical Director of JeffConnect, fellowship director of the Telehealth fellowship at Thomas Jefferson University and current Chair of the ACEP Telehealth Committee. She has worked in this modality for over 7 years at both a startup and currently a large academic program in a multifaceted role including operations for acute care, administrative processes, education and training of all levels of learners. She is considered an expert in acute care telehealth and its future use in EM.

Gary Bennett, PhD

Gary Bennett, PhD

Bishop-MacDermott Family Professor of Psychology & Neuroscience, Global Health and Medicine and Vice Provost for Undergraduate Education at Duke University

Gary G. Bennett, Ph.D. is the Bishop-MacDermott Family Professor of Psychology & Neuroscience, Global Health and Medicine and Vice Provost for Undergraduate Education at Duke University. As vice provost, Dr. Bennett drives Duke’s undergraduate education strategy, leads curricular and co-curricular programs, and serves as the university’s primary spokesperson for undergraduate concerns. He directs Duke’s Office of Undergraduate Education, which is comprised of 12 units (including academic advising, academic support, nationally competitive scholarships, merit scholar programs, financial aid, study abroad, as well as vibrant co-curricular programs like Duke Engage and Duke Immerse) that enrich Duke’s undergraduate academic experience. Dr. Bennett is the founding director of the Duke Digital Health Science Center and Past-President of the Society of Behavioral Medicine.

Register for our upcoming webinars

A Healthy Disruption 02

Reimagining Population Health Management

Can Genomics Evolve our Sick Care System into a True Healthcare System

Date: December 15, 2020
Time: 11:30 am – 12:30 pm PST

Imagine if our healthcare system could actually prevent us from becoming patients in the first place.

In today’s healthcare, we use only 10% of the data that predicts health outcomes. Genetic information has the potential to radically improve our predictive power and to help risk-stratify the patients at highest and lowest risk of common chronic diseases such as diabetes, cardiovascular disease, and hypertension.

This webinar will explore how using genetics as a routine part of our healthcare can help us improve population health management—by identifying the highest-risk patients and proactively delivering personalized, preventive interventions to the right patients at the right time.

Key themes

  • The channels, tools, and delivery methods that could be used for population health management;
  • How genomics can be paid for when applied as a population health management tool in the transition to value-based care; and
  • How digital health companies should think about building solutions for population health management.

Panelists:

Tony Slonim, MD, DrPH, FACHE

President and CEO, Renown Health

Chet Robson, DO, MHCDS, FAAFP

Chief Clinical Officer, Walgreens

Professor Sir Peter Donnelly, FRS FMedSci

Founder and CEO, Genomics plc

Marcia Guida, MS-CH, MBA, MS-HP,CPC

Senior Director, Value Based Contracting and Medicare Network Operations, Aetna CVS Health

Share This